THYROID Volume 24, Number 10, 2014 ª Mary Ann Liebert, Inc. DOI: 10.1089/thy.2014.0429
EDITORIALS and COMMENTARY
Welcome to the 84th Annual Meeting of the American Thyroid Association R. Michael Tuttle1 and Fredric E. Wondisford 2
O
n behalf of the Annual Meeting Steering Committee, it is our great pleasure to invite you to join us at the 84th annual meeting of the American Thyroid Association to be held from October 29 to November 2, 2014, at the Hotel del Coronado in Coronado, California. The committee has worked hard to organize a creative and innovative fourday program designed to highlight the most recent advances in both clinical and basic science thyroidology, as well as to explore current controversies in the clinical management of patients with thyroid disease. As has been our tradition, the combined ATA/AACE Advanced Endocrine Neck Ultrasound Course will be offered concurrently with an outstanding ATA Trainees Track Program (which will continue throughout the meeting proper) on Wednesday prior to the official start of our meeting. The meeting officially opens on Wednesday evening with a series of superb review lectures designed to provide the most up-to-date view of recent developments and future challenges in thyroid basic science by Dr. Peter Kopp, clinical thyroidology by Dr. Douglas Ross, and surgical thyroidology by Dr. Herb Chen. Each year, the plenary lectures are recognized as one of the major highlights of the annual meeting. This year will be no exception with Dr. Mark Robson discussing the ‘‘Clinical, ethical and legal implications of incidental germline findings discovered as part of sequencing studies’’ and Dr. Rolf Karlstrom describing the relationship between ‘‘Excess thyroid hormone and thyrotroph cell death.’’ Our named lecture series this year will once again be outstanding with Dr. Leonard Wartofsky giving the Lewis E. Braverman Award lecture, Dr. Peter Kopp giving the Clark T. Sawin Historical Vignette, and Dr. Gil Daniels presenting the Paul Starr Award Lecture. Of course, the winner of the Van Meter Lecture is a closely guarded secret that will be announced at the meeting. Each year, the research presentations (both oral and poster presentations) provide exciting insights into the most current work being done around the world in thyroidology. We encourage everyone to participate actively in both the question and answer periods of the oral abstracts, and the poster viewing times. The posters will be arranged in close prox1 2
imity to the ATA Expo Theater so there will be easy access to industrial colleagues and exhibits that are educational and informative. A wide variety of Meet the Professor Workshops will explore exciting topics from both a clinical and basic/translational perspective. Sessions on thyroid hormone transporters, the ATA Basic Science Handbook, genome wide analysis of signaling, and ATA guidelines regarding how to manipulate thyroid status in animal models promise to provide basic and translational scientist with critical updates. Clinical Meet the Professor sessions will cover topics as diverse as thyroid disease and pregnancy, thyrotropin (TSH) suppression in thyroid cancer, the after effects of the Fukushima Daiichi accident, the role of molecular testing in thyroid nodules, radioactive iodine therapy of benign goiter, and the potential role of BRAF mutational status in thyroid cancer initial management decisions. In addition to the Meet the Professor sessions, the meeting will also offer a series of informative and exciting symposiums dealing with diverse topics that will include evaluation of voice issues associated with thyroid surgery, an update on autoimmunity, immune-modulators and thyroid dysfunction, iodine deficiency, ethical dilemmas for thyroid practitioners, and an update on the ATA guidelines on thyroid nodules and cancer, medullary thyroid cancer, and hypothyroidism. The basic science symposium will explore important topics such as thyroid cell biology (dedicated to the memory of Paul Kim), thyroid hormone regulation of growth and development, and insights from disease models with respect to thyroid hormone receptors This year, the early riser symposia will focus on the care of patients with thyroid cancer in sessions offered on three separate mornings: medullary thyroid cancer (Thursday morning), radioactive iodine remnant ablation (Friday morning), and advanced radioactive iodine-refractory thyroid cancer (Saturday morning). Our final day will provide an outstanding review of the contemporary evaluation and management of thyroid nodules in addition to the very popular thyroid cancer tumor board, which will end our meeting. While the scientific and educational opportunities of our meeting are paramount, we also encourage everyone to take
Memorial Sloan Kettering Cancer Center, New York, New York. Johns Hopkins University School of Medicine, Baltimore, Maryland.
1439
1440
advantage of the numerous amenities of the Hotel del Coronado, Coronado island, and San Diego. We have no doubt that this meeting will once again provide the scientific venue for discussion, debate, and learning and, just as importantly, encourage social interactions as we celebrate the world of thyroid research and thyroid clinical care as friends and colleagues.
EDITORIAL
Address correspondence to: R. Michael Tuttle, MD Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, NY 10021 E-mail: [email protected]
EDITORIALS and COMMENTARY
Welcome to the 84th Annual Meeting of the American Thyroid Association R. Michael Tuttle1 and Fredric E. Wondisford 2
O
n behalf of the Annual Meeting Steering Committee, it is our great pleasure to invite you to join us at the 84th annual meeting of the American Thyroid Association to be held from October 29 to November 2, 2014, at the Hotel del Coronado in Coronado, California. The committee has worked hard to organize a creative and innovative fourday program designed to highlight the most recent advances in both clinical and basic science thyroidology, as well as to explore current controversies in the clinical management of patients with thyroid disease. As has been our tradition, the combined ATA/AACE Advanced Endocrine Neck Ultrasound Course will be offered concurrently with an outstanding ATA Trainees Track Program (which will continue throughout the meeting proper) on Wednesday prior to the official start of our meeting. The meeting officially opens on Wednesday evening with a series of superb review lectures designed to provide the most up-to-date view of recent developments and future challenges in thyroid basic science by Dr. Peter Kopp, clinical thyroidology by Dr. Douglas Ross, and surgical thyroidology by Dr. Herb Chen. Each year, the plenary lectures are recognized as one of the major highlights of the annual meeting. This year will be no exception with Dr. Mark Robson discussing the ‘‘Clinical, ethical and legal implications of incidental germline findings discovered as part of sequencing studies’’ and Dr. Rolf Karlstrom describing the relationship between ‘‘Excess thyroid hormone and thyrotroph cell death.’’ Our named lecture series this year will once again be outstanding with Dr. Leonard Wartofsky giving the Lewis E. Braverman Award lecture, Dr. Peter Kopp giving the Clark T. Sawin Historical Vignette, and Dr. Gil Daniels presenting the Paul Starr Award Lecture. Of course, the winner of the Van Meter Lecture is a closely guarded secret that will be announced at the meeting. Each year, the research presentations (both oral and poster presentations) provide exciting insights into the most current work being done around the world in thyroidology. We encourage everyone to participate actively in both the question and answer periods of the oral abstracts, and the poster viewing times. The posters will be arranged in close prox1 2
imity to the ATA Expo Theater so there will be easy access to industrial colleagues and exhibits that are educational and informative. A wide variety of Meet the Professor Workshops will explore exciting topics from both a clinical and basic/translational perspective. Sessions on thyroid hormone transporters, the ATA Basic Science Handbook, genome wide analysis of signaling, and ATA guidelines regarding how to manipulate thyroid status in animal models promise to provide basic and translational scientist with critical updates. Clinical Meet the Professor sessions will cover topics as diverse as thyroid disease and pregnancy, thyrotropin (TSH) suppression in thyroid cancer, the after effects of the Fukushima Daiichi accident, the role of molecular testing in thyroid nodules, radioactive iodine therapy of benign goiter, and the potential role of BRAF mutational status in thyroid cancer initial management decisions. In addition to the Meet the Professor sessions, the meeting will also offer a series of informative and exciting symposiums dealing with diverse topics that will include evaluation of voice issues associated with thyroid surgery, an update on autoimmunity, immune-modulators and thyroid dysfunction, iodine deficiency, ethical dilemmas for thyroid practitioners, and an update on the ATA guidelines on thyroid nodules and cancer, medullary thyroid cancer, and hypothyroidism. The basic science symposium will explore important topics such as thyroid cell biology (dedicated to the memory of Paul Kim), thyroid hormone regulation of growth and development, and insights from disease models with respect to thyroid hormone receptors This year, the early riser symposia will focus on the care of patients with thyroid cancer in sessions offered on three separate mornings: medullary thyroid cancer (Thursday morning), radioactive iodine remnant ablation (Friday morning), and advanced radioactive iodine-refractory thyroid cancer (Saturday morning). Our final day will provide an outstanding review of the contemporary evaluation and management of thyroid nodules in addition to the very popular thyroid cancer tumor board, which will end our meeting. While the scientific and educational opportunities of our meeting are paramount, we also encourage everyone to take
Memorial Sloan Kettering Cancer Center, New York, New York. Johns Hopkins University School of Medicine, Baltimore, Maryland.
1439
1440
advantage of the numerous amenities of the Hotel del Coronado, Coronado island, and San Diego. We have no doubt that this meeting will once again provide the scientific venue for discussion, debate, and learning and, just as importantly, encourage social interactions as we celebrate the world of thyroid research and thyroid clinical care as friends and colleagues.
EDITORIAL
Address correspondence to: R. Michael Tuttle, MD Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, NY 10021 E-mail: [email protected]
